JK Ramage*, AHG Davies*, J ArdillÀ, N BaxÀ, M CaplinÀ, A GrossmanÀ, R HawkinsÀ, AM
McNicolÀ, N ReedÀ, R Sutton, R ThakkerÀ, S Aylwin, D Breen, K Britton, K Buchanan, P …

These guidelines update previous guidance published in 2005. They have been revised by
a group who are members of the UK and Ireland Neuroendocrine Tumour Society with …

R. Garcia-Carbonero a H. Sorbye b E. Baudin c E. Raymond d B. Wiedenmann e B. Niederle
f E. Sedlackova g C. Toumpanakis h M. Anlauf i JB Cwikla j M. Caplin k D. O'Toole l A …

The diagnostic work-up and treatment of patients with neuroendocrine tumours has
undergone a major change during the last decade. New diagnostic possibilities and …

Neuroendocrine gastroenteropancreatic tumours (GEP-NET) constitute a heterogeneous
group of tumours with their origin in neuroendocrine cells of the embryological gut, most …

Progress in the diagnostics and therapy of gastro-entero-pancreatic (GEP) neuroendocrine
neoplasms (NEN), the published results of new randomised clinical trials, and the new …

Ramon Salazar a Bertram Wiedenmann b Guido Rindi c Philippe Ruszniewski d aInstitut
Català D'Oncologia (IDIBELL), Barcelona, Spain; bDepartment of Hepatology and …

Barbro Eriksson a Günter Klöppel b Eric Krenning c Hakan Ahlman d Ursula Plöckinger e
Bertram Wiedenmann e Rudolf Arnold f Christoph Auernhammer g Meike Körner h Guido …

Background The diagnostic work-up and treatment of patients with gastroenteropancreatic
(GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods …

The participants at the conference were asked to focus on the relevant literature published
between 2011 and 2015. They met over two and a half days, in which data and new …